Found vs Gala: Which GLP-1 Provider Is Better?
Short answer: Found scores higher on our rubric, 7.3/10 against 7.2/10. Full reasoning, pricing and the cases where the other one wins are below.
Found beats Gala overall, scoring 7.3/10 vs 7.2/10. Published pricing is not a like-for-like monthly comparison: Found is published $148/mo; total not verified; Gala is from $149/mo. Choose Found for patients with commercial insurance who want their glp-1 coverage checked before they pay, and medicare part d members aged 65 to 75 going through the glp-1 bridge. Choose Gala for patients who want gala's low yearly-plan rate on compounded glp-1, $149/mo microdose or $179/mo with all doses included, and will use its free companion app for daily progress logging.
A side-by-side look at Found and Gala to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Found
#27 of 54Science-backed weight management platform combining GLP-1 medications with behavioral health coaching and support.
Visit FoundGala
#30 of 54Telehealth platform whose compounded GLP-1 line covers semaglutide and tirzepatide, sold as a $149/mo microdose tier and a $179/mo all-doses tier, alongside brand-name Ozempic at $1,299/mo and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. of Wilmington, Delaware, with care delivered by OpenLoop-affiliated medical groups; Gala states it provides administrative, technology and management services and does not itself provide medical care. It is LegitScript verified and promotes a free Gala GLP-1 app for in-treatment dosing, weight and side-effect logging.
Visit Gala| Feature | Found | Gala |
|---|---|---|
| Why each one | One of the only GLP-1 platforms that actively coordinates with insurance companies, offers a GLP-1 coverage check, and prescribes from 10+ medications. | A free Gala GLP-1 companion app, paired with a $149/mo microdose tirzepatide tier on a yearly commitment plan; confirm the app's availability for your phone before enrolling. |
| Our Score | 7.3/10 | 7.2/10 |
| Headline Price | published $148/mo; total not verified | from $149/mo |
| Medication Type | Both | Both |
| Insurance Accepted | Yes | No |
| Best For | Patients with commercial insurance who want their GLP-1 coverage checked before they pay, and Medicare Part D members aged 65 to 75 going through the GLP-1 Bridge | Patients who want Gala's low yearly-plan rate on compounded GLP-1, $149/mo microdose or $179/mo with all doses included, and will use its free companion app for daily progress logging |
| Watch out for | The advertised prices need a 12 month plan paid up front. Found's pricing page lists $169/mo cash or $99/mo insured on that plan, and $289/mo cash or $199/mo insured if you pay month to month | Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded GLP-1 line. |
| Ranking | #27 | #30 |
| Get started | Visit Found | Visit Gala |
Pros & Cons Compared
Found
Pros
- +Active insurance coordination, Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
- +10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill), the widest formulary of any platform
- +With insurance the plan starts at $99/mo on a 12 month term, below its own $169/mo cash figure, plus a copay Found puts at around $30 for most members
- +Most members start treatment within one week of completing the health questionnaire
Cons
- −The advertised prices need a 12 month plan paid up front. Found's pricing page lists $169/mo cash or $99/mo insured on that plan, and $289/mo cash or $199/mo insured if you pay month to month
- −The insurance route adds steps compared with flat cash-pay platforms, and the copay Found quotes at around $30 for most members is charged on top of the plan price, not instead of it
- −Compounded medication availability may shift with FDA enforcement changes; the 10+ medication formulary lets your clinician move you to a brand-name option if it does
Gala
Pros
- +Compounded GLP-1 is $149/mo on the microdose tier or $179/mo with all doses included on the yearly plan, and Gala's about page lists GLP-1 medication from $199/mo on a 3-month plan
- +A free Gala GLP-1 app for in-treatment logging, promoted in the footer of every page; first-party logging is uncommon among compounded-only platforms
- +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
- +All 50 states, free shipping, no insurance required, 24/7 patient support claimed
Cons
- −Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded GLP-1 line.
- −Product pages quote only the yearly subscription, its about page lists a 3-month GLP-1 plan from $199/mo, and the plan you actually get is set at checkout after you log in
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness, verify your specific dose and batch with each refill
- −Initial consultation is typically a sync video visit, but ongoing follow-ups are chat-based (no scheduled ongoing video access), and Gala publishes no lab panel for the GLP-1 program, no named medical director and no specialty obesity oversight; its refund policy does list lab services among what the subscription price may cover
- −Restrictive refund policy, Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
- −Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn), limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself
Our Verdict
Found edges out Gala with a score of 7.3/10 vs 7.2/10. Published pricing is not a like-for-like monthly comparison: Found is published $148/mo; total not verified; Gala is from $149/mo. Found accepts insurance, which can significantly reduce your out-of-pocket costs.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Found and Gala.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare Found and Calibratepublished $199/mo; total not verified
- Compare Found and Eden Health GLP-1$99/mo month-to-month
- Compare Found and Sprout Health$110/mo flat
- Compare Gala and DudeMedsfrom $149/mo
- Compare Gala and Hers$188 first month, then $298/mo
- Compare Gala and Shedfrom $159/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Found legit and is Gala legit, with the verification evidence behind each answer.
Our pick of these two: Found · 7.3/10